Interventional Strategies in Cancer-induced Cardiovascular Disease.

Autor: Pushparaji B; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1451, Houston, TX, 77030, USA.; Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY, USA., Donisan T; Department of Internal Medicine, Beaumont Hospital, Royal Oak, MI, USA., Balanescu DV; Department of Internal Medicine, Beaumont Hospital, Royal Oak, MI, USA., Palaskas N; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1451, Houston, TX, 77030, USA., Kim P; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1451, Houston, TX, 77030, USA., Lopez-Mattei J; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1451, Houston, TX, 77030, USA., Cilingiroglu M; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1451, Houston, TX, 77030, USA.; School of Medicine, Bahcesehir University, Istanbul, Turkey., Hassan SA; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1451, Houston, TX, 77030, USA., Boudoulas KD; The Ohio State University Wexner Medical Center, Columbus, OH, USA., Marmagkiolis K; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1451, Houston, TX, 77030, USA.; HCA Northside Hospital, St. Petersburg, FL, USA., Hajjar LA; Instituto Do Coração, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Iliescu CA; Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1451, Houston, TX, 77030, USA. ciliescu@mdanderson.org.
Jazyk: angličtina
Zdroj: Current oncology reports [Curr Oncol Rep] 2021 Sep 27; Vol. 23 (11), pp. 133. Date of Electronic Publication: 2021 Sep 27.
DOI: 10.1007/s11912-021-01113-y
Abstrakt: Purpose of Review: To highlight the range of illnesses and procedures that the interventional onco-cardiologists face in their daily practice, along with the recent additions to anti-cancer therapies and their related cardiotoxicity.
Recent Findings: Immune checkpoint inhibitors (ICI) are not devoid of cardiotoxicity as thought earlier and lead to an increased incidence of myocarditis. Transcatheter valve replacement has been shown to be a safer alternative to surgical replacement in cancer patients. Interventional onco-cardiology is a novel field that addresses cardiovascular diseases in the setting of cancer. Traditionally excluding cancer patients from clinical trials has led to a dearth of information needed to tackle cardiac conditions like Takotsubo cardiomyopathy, malignant pericardial effusions, and radiation-induced vascular diseases encountered either exclusively or predominantly in this high-risk population. This review discusses the various treatment options available in the interventional armamentarium with a particular focus on ICI-myocarditis and transcatheter aortic valve replacement in cancer patients.
(© 2021. The Author(s).)
Databáze: MEDLINE
Externí odkaz: